Search

Your search keyword '"MANSUETO, GIOVANNI"' showing total 433 results

Search Constraints

Start Over You searched for: Author "MANSUETO, GIOVANNI" Remove constraint Author: "MANSUETO, GIOVANNI"
433 results on '"MANSUETO, GIOVANNI"'

Search Results

102. Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

103. Mental pain and pain-proneness in patients with migraine: results from the PAINMIG cohort-study

106. Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases

108. The Role of Anxiety Sensitivity and Expectancy Manipulation on Panic-Like Response to the 35% CO2 Challenge in Healthy Subjects.

109. Metacognitive beliefs and childhood adversities: an overview of the literature.

110. Correction: Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases

111. Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

113. Natural History of Non-Small-Cell Lung Cancer with Bone Metastases

114. The DSM-5 effect: psychological characteristics of new patients affected by Binge Eating Disorder following the criteria of the DSM-5 in a sample of severe obese patients

115. Cabazitaxel after Docetaxel in patients with metastatic, castration-resistant, prostate cancer (mCRPC): A prospective, observational study about toxicity profile and quality of life.

117. [Erlotinib in the treatment of NSCLC: current and novel prospects from the ASCO 2006]

119. Natural history of malignant bone disease in non-small cell lung cancer: Preliminary results of a multicenter bone metastasis survey.

120. Temozolomide (TMZ) maintenance in patients with primary brain cancer treated with postoperative TMZ plus radiotherapy (RT): A retrospective analysis.

121. The predictive value of clinical variables in patients affected with non-small-cell lung cancer (NSCLC) treated with pemetrexed (PEM) plus platinum-based regimen: A retrospective analysis.

124. Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

125. Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy

134. The Combination of the Selective Cyclooxygenase-2 Inhibitor Celecoxib with Weekly Paclitaxel Is a Safe and Active Second-Line Therapy for Non-Small Cell Lung Cancer

148. Second line treatment of antiangiogenic therapy with celecoxib and weekly paclitaxel for advanced non-small cell lung cancer (NSCLC)

Catalog

Books, media, physical & digital resources